Applying the System Asset Pricing Model to Molecular Persistence

Each dollar of persistence revenue destroys $35 of system welfare

The global molecular persistence economy generates 186.7 billion per year in Persistence Premium. SAPM reveals that each dollar of that payoff is associated with 35.20 in system welfare cost — yielding total annual welfare destruction of approximately $6.6 trillion.

• System beta β_W = 35.2 [90% CI: 25.5–50.9]
• System-adjusted payoff Π^SA = −$6,519.9 B/yr (Monte Carlo median)
• Breakeven shadow price μ* = 0.972 — 97.2% of welfare cost must be internalized for net positive payoff

Same covariance logic, different question

CAPM asks how an asset co-moves with market returns. SAPM asks how an activity's private payoff co-moves with system welfare destruction.

• CAPM: E[R_i] = R_f + β_i(E[R_m] − R_f)
• SAPM: System-adjusted payoff Π^SA = Π − β_W·Π
• β_W = −dW/dΠ: marginal welfare cost per dollar of industry revenue

$186.7 billion in revenue depends on molecules that never break down

The carbon-fluorine bond (485 kJ/mol) is the strongest in organic chemistry — 40% stronger than C-C. That bond is engineered into over 10,000 compounds, and its non-degradability is the source of commercial value.

• PFAS, microplastics, and POPs generate $186.7 B/yr in Persistence Premium across nine sectors
• Adding PFAS to a product costs 50–1,000 per pound; removing it from water costs 2.7–18 million per pound — a ratio of 2,700:1 to 18,000:1
• Semiconductor fabs achieve >99% capture at 0.002–13 g/day per fab — empirical lower bound of the Molecular Persistence Floor

Healthcare and environmental stock dominate the welfare cost

Six channels of Private-Systemic Tension are monetized: water remediation (5% weight), healthcare (48%), agriculture (12%), bioaccumulation (structural bound), regulatory transition (3%), and environmental stock (32%).

• Healthcare channel: $1.5 trillion/yr in health losses from plastics alone (Lancet, 2025)
• U.S. PFAS health costs: 5.52–63 billion/yr (Obsekov & Kahn, 2022)
• Water infrastructure liability: 140–170 billion in U.S. alone (Milliman)
• EU PFAS healthcare costs: €52–84 billion/yr (Nordic Council)

Weighted-average β_W = 35.2, Monte Carlo robust

Channel-specific betas are weighted by each channel's share of total welfare cost. Monte Carlo analysis with 100,000 draws yields 90% CI [25.5, 50.9].

• Healthcare channel β = 8.4; environmental stock channel β = 11.3
• Even if healthcare costs drop by 90%, aggregate β_W ≈ 4.5 — classification unchanged
• System beta is a contemporaneous ratio: no discount rate needed

No market mechanism can reduce β below ~2.5

The Molecular Persistence Floor is a deductive proof: under three axioms of commodity chemistry (Functional Necessity, Open-Release Architecture, Environmental Non-Degradability), private action alone cannot push β_W below approximately 2.5.

• Axiom A1: Functional Necessity — no single PFAS-free compound matches all PFAS properties
• Axiom A2: Open-Release Architecture — most applications disperse molecules into the environment
• Axiom A3: Environmental Non-Degradability — C-F bond half-life exceeds human planning horizons
• Contained vs. open-release bifurcation: β = 2.5 vs. β > 50

Pigouvian taxes fail when welfare is structurally independent of payoffs

The Missing System Theorem proves that when private payoffs and system welfare are structurally independent, every privately efficient outcome degrades the system. No Pigouvian tax computed from bilateral transaction data can internalize welfare costs that are structurally independent of the payoff space.

• Coasean failure: affected parties include unborn generations who cannot bargain
• Property rights over environmental receptor capacity are undefined
• The externality is temporally dispersed (centuries) and spatially diffuse (every continent except Antarctica)

Slow Hollow Win: multi-generational latency, irreversible stock

The molecular persistence economy is classified as a Slow Hollow Win — all transacting parties achieve privately positive payoffs while system welfare is degraded. Unlike Bitcoin's Fast Hollow Win (years), this operates on generational timescales.

• Persistence Premium declines as alternatives arrive; environmental stock does not
• Chemical debt: principal (stock) compounds at release rate; interest (remediation cost) compounds at tech failure rate
• Cannot be discharged through bankruptcy

Thresholds converge within decades — feedback loops accelerate collapse

Majority U.S. water contamination by 2035–2045; blood microplastic thresholds already crossed; semiconductor manufacturing at risk 2040–2070; marine extinction cascades by ~2060.

• PFAS >50% of public water systems contaminated by 2035–2045 (detection), ~2055 (MCL)
• Microplastics in brain tissue: concentrations 50% higher in 2024 vs. 2016
• Full containment of existing stock: 50–100 years

Four institutional game transformations — and one rollback

The EU REACH Universal PFAS Restriction, EPA NPDWR (April 2024), Stockholm Convention Annex A expansion, and U.S. state-level PFAS bans represent the first documented game transformations. The Trump Administration's 2025 partial rollback was denied by the D.C. Circuit in January 2026.

• Substance-specific bans shift the persistence floor (e.g., 3M replaced PFOS with PFBS — still persistent)
• Only class-wide restrictions escape the Substitution Lemma
• The answer for open-release applications is stop

System beta replaces discount-rate debates with a single finite ratio

The SAPM sidesteps the Nordhaus–Stern–Weitzman discount-rate paralysis. System beta is a contemporaneous ratio — no discount rate, no intergenerational weighting, no non-convergent integral.

• DICE-2023: $66/tCO₂ at ~3% discount rate; Stern: multiples at ~1.4%; Weitzman: integral diverges
• SAPM: one number — 35.2 — independent of any discount rate
• Policy implication: sovereign prohibition of open-release deployment architecture, not market correction

Four criteria that could disprove the model

The SAPM framework is designed to be falsified. Specific criteria are provided for each major claim.

• Falsify β_W = 35.2: show total welfare cost < $186.7B
• Falsify Molecular Persistence Floor: demonstrate convex PSF under A1–A3
• Falsify Slow Hollow Win classification: show Π^SA ≥ 0 at any shadow price μ ≤ 1
• Falsify Pigouvian Insufficiency: identify a bilateral transaction that internalizes welfare costs structurally independent of payoff space